October 29 · 31 2026

Venice · Italy

Topics

How to approach cardiac arrhythmias in pediatric age, elderly, pregnancy

01

Arrhythmias in different metabolic and systemic disorders

02

Sport & cardiac arrhythmias

03

ECG in complex arrhythmias: a Master view

04

Value of cardiac imaging before and during ablation procedures

05

Cardiac anatomy for the interventional EP

06

Catheter ablation of complex SVT: nightmare cases

07

AF predictors, comorbidity and risk factors modification in the management of AF

08

AF screening: who, when and how

09

Wearable devices for AF: how to move in the jungle

10

Subclinical AF: to anticoagulate or not to anticoagulate?

11

Control rhythm in asymptomatic AF: why and when

12

AF and inherited cardiac channelopathies. Which relationship?

13

AF management in different cardiomyopathy phenotypes

14

AF and risk of dementia

15

Anticoagulation therapy for AF: practical aspects

16

LAA occlusion: technologies and outcomes

17

Role of non antiarrhythmic drugs to prevent AF: Antidyslipidemic drugs:, SGLT2 inhibitors GLP-1 and dual GIP/GLP-1 receptor agonists

18

PFA for AF catheter ablation: new standard care?

19

Successful AF ablation and anticoagulation: 2026 update

20

AF and HF: how to interrupt the vicious circle?

21

Role of different tools to diagnose the cause of syncope

22

Vasovagal syncope management in 2026

23

Cardioneuroablation for treatment of vasovagal syncope and functional bradyarrhythmias. Why, when and how?

24

Evaluation and management of syncope in special situations

25

Antiarrhythmic drugs: from 2026 consensus document to clinical practice

26

Anti-arrhythmic drugs in special situations

27

Different physiological pacing methods: when and how

28

Conduction system pacing in different clinical settings

28

Leadless pacemakers: pearls and pittfalls

29

CRT in the era of conduction system pacing

30

Lead extraction and device infection: What is new?

31

Arrhythmic emergencies in ICU: How to afford them?

32

Arrhythmogenic hereditary syndromes: What is new in 2026?

33

PVCs in different clinical settimgs: clinical significance and treatment

34

VT management: drugs, ablation or ICD?

35

VT ablation: technologies, approaches, outcomes

36

Cardiac neuromodulation for the treatment of ventricular arrhythmias

37

Sudden death risk stratification and prevention in different clinical settings

38

ICD controversial indications: implant, don’t implant or even remove

39

What type of ICD to implant: wearable vs extravascular vs SQ vs TV, single vs dual

40

CRT-P vs CRT-D: Pro & Cons

41

CRT-P vs CRT-D: Pro & Cons

42

Living with an ICD: work, sports, driving and sex

43

Value of digital health and AI for the management of cardiac arrhythmias

44

Remote monitoring for CIEDs: state of the art and future perpectives

45

EP live cases

46